Literature DB >> 9662412

Inhibition of mouse and human CYP 1A- and 2E1-dependent substrate metabolism by the isoflavonoids genistein and equol.

N A Helsby1, J K Chipman, A Gescher, D Kerr.   

Abstract

The inhibitory effect of the isoflavonoids genistein and equol on cytochrome P450 activities has been investigated. Genistein and equol inhibited the high capacity component of p-nitrophenol (CYP2E1 substrate) metabolism in liver microsomes from acetone-induced mice with IC50 values of approximately 10 mM and 560 microM, respectively (cf. diethyldithiocarbamate, IC50, 69 microM). Using human CYP2E1 from a specific expression system (which overcame multienzyme involvement in the rodent system), non-competitive inhibition was also seen with both isoflavonoids. Genistein and equol also inhibited the high capacity component of ethoxyresorufin (CYP1A substrate) metabolism in liver microsomes from beta-naphthoflavone-induced mice with IC50 values of 5.6 mM and 1.7 mM, respectively (cf. alpha-naphthoflavone, IC50 0.8 microM). Using human CYPIA2 from a specific expression system, noncompetitive inhibition was seen with both isoflavonoids. CYP1A1 inhibition offers a possible explanation for the chemopreventative effect of genistein against, for example, dimethylbenz[a]anthracene genotoxicity reported in animals but the IC50 values negate the relevance of this specific chemopreventative action at the levels likely to be achieved from the human diet.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9662412     DOI: 10.1016/s0278-6915(97)00171-3

Source DB:  PubMed          Journal:  Food Chem Toxicol        ISSN: 0278-6915            Impact factor:   6.023


  8 in total

1.  Genistein alters caffeine exposure in healthy female volunteers.

Authors:  Yao Chen; Chang-Qiong Xiao; Yi-Jing He; Bi-Lian Chen; Guo Wang; Gan Zhou; Wei Zhang; Zhi-Rong Tan; Shan Cao; Li-Ping Wang; Hong-Hao Zhou
Journal:  Eur J Clin Pharmacol       Date:  2010-12-14       Impact factor: 2.953

2.  Sex hormone modulation of both induction and inhibition of CYP1A by genistein in HepG2/C3A cells.

Authors:  Yitong Liu; Michael F Santillo; Thomas J Flynn; Martine S Ferguson
Journal:  In Vitro Cell Dev Biol Anim       Date:  2014-12-06       Impact factor: 2.416

Review 3.  Effects of soy containing diet and isoflavones on cytochrome P450 enzyme expression and activity.

Authors:  Martin J J Ronis
Journal:  Drug Metab Rev       Date:  2016-07-20       Impact factor: 4.518

4.  Chemical proteomic probes for profiling cytochrome p450 activities and drug interactions in vivo.

Authors:  Aaron T Wright; Benjamin F Cravatt
Journal:  Chem Biol       Date:  2007-09

5.  Inhibition of major drug metabolizing CYPs by common herbal medicines used by HIV/AIDS patients in Africa-- implications for herb-drug interactions.

Authors:  Charles Awortwe; Patrick J Bouic; Collen M Masimirembwa; Bernd Rosenkranz
Journal:  Drug Metab Lett       Date:  2014-07

6.  Effect of simvastatin and naringenin coadministration on rat liver DNA fragmentation and cytochrome P450 activity: an in vivo and in vitro study.

Authors:  T K Motawi; Z A Teleb; N A El-Boghdady; S A Ibrahim
Journal:  J Physiol Biochem       Date:  2013-11-22       Impact factor: 4.158

Review 7.  Potential health-modulating effects of isoflavones and metabolites via activation of PPAR and AhR.

Authors:  Svjetlana Medjakovic; Monika Mueller; Alois Jungbauer
Journal:  Nutrients       Date:  2010-02-26       Impact factor: 5.717

8.  Soybean greatly reduces valproic acid plasma concentrations: a food-drug interaction study.

Authors:  Anu Marahatta; Bidur Bhandary; Seul-Ki Jeong; Hyung-Ryong Kim; Han-Jung Chae
Journal:  Sci Rep       Date:  2014-03-12       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.